Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.

Source:http://linkedlifedata.com/resource/pubmed/id/20733003

Download in:

View as

General Info

PMID
20733003